PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
29-Apr-2020 Audited results for the year ended 31 December 2019 and clinical development update Destiny Pharma plc
29-Apr-2020 Sanofi: Annual General Meeting of April 28, 2020 sanofi
29-Apr-2020 Bone Therapeutics secures EUR 11.0 million financing Bone Therapeutics
29-Apr-2020 Polyplus' growth investment expands partnership with Warburg Pincus and ArchiMed Polyplus-transfection
29-Apr-2020 Elasmogen Ltd to deploy their soloMER technology platform to develop tools to combat COVID-19 Elasmogen Ltd
29-Apr-2020 Almac Discovery to Collaborate with MSD on selected DUB therapeutic targets Almac
29-Apr-2020 Let local clinicians and managers lead the redesign of services NHS England
29-Apr-2020 Richmond Research Institute partnering to ensure faster COVID-19 point of care testing and longer-term immunity studies Richmond Research Institute
29-Apr-2020 Independent site management organisation Panthera expands vaccine trial capacity Panthera Biopartners
29-Apr-2020 NOVOTECH Selected as CRO for Karyopharm's COVID-19 Clinical Study Novotech CRO
28-Apr-2020 Valo Therapeutics to Support Development of a Pan – Coronavirus Vaccine Valo Therapeutics
28-Apr-2020 SHIONOGI RECEIVES EUROPEAN COMMISSION MARKETING AUTHORISATION FOR FETCROJA® (CEFIDEROCOL) FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH LIMITED TREATMENT OPTIONS Shionogi & Co., Ltd
28-Apr-2020 COVID-19 Could Reshape Mental Health Treatment Flow Neuroscience
28-Apr-2020 MARINOMED RECEIVES FFG FUNDING TO RESEARCH SARS-CoV-2 THERAPY BASED ON CARRAGELOSE® Marinomed Biotech AG
28-Apr-2020 MR Solutions now offers the widest range of preclinical nuclear medicine imaging systems MR Solutions
28-Apr-2020 Healthcare Communications Volunteers Website Launched by HCA Healthcare Communications Association (HCA)
28-Apr-2020 OBN Announces the Launch of OBN Ventures™ OBN
28-Apr-2020 Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients Sanofi
28-Apr-2020 Six COVID-19 Patients Treated with RedHill’s Opaganib Under Compassionate Use Show Objective Clinical Improvement RedHill Biopharma
28-Apr-2020 Orgenesis completes acquisition of Tamir Biotechnology, Inc. assets including broad spectrum antiviral platform Orgenesis